A PhaseⅡ Study to Evaluate the Safety and Immunogenicity of COVID-19 Vaccine

NCT06113731 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

980

Enrollment

INDUSTRY

Sponsor class

Conditions

SARS-CoV-2 Infection

Interventions

BIOLOGICAL: COVID-19 mRNA Vaccine (ZSVG-02-O)
BIOLOGICAL: COVID-19 mRNA Vaccine (ZSVG-02-O)
BIOLOGICAL: COVID-19 Vaccine (Vero Cell) ,Inactivated

Sponsor

CNBG-Virogin Biotech (Shanghai) Ltd.